Genetics of Atropine for Myopia control in childrEn

Genetics of Atropine for Myopia control in childrEn - GAME

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030053

Enrollment

300

Registered

2023-07-17

Start date

2023-06-27

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H52.1

Interventions

Group 1: One-time collection of oral mucosa swabs

Eligibility

Sex/Gender

All

Age

8 Years to 15 Years

Inclusion criteria

Inclusion criteria: Participation in the AIM study, written informed consent obtained from the patient and his/her parents/legal guardians

Exclusion criteria

Exclusion criteria: No written informed consent

Design outcomes

Primary

Measure	Time frame
Correlating a myopia risk score with the efficacy of low-dose atropine therapy	—

Secondary

Measure	Time frame
Correlating other myopia and atropine related polymorphisms with the efficacy of low-dose atropine therapy	—

Countries

Germany

Contacts

Public ContactNavid Farassat

Universitätsklinik Freiburg, Klinik für Augenheilkunde

navid.farassat@uniklinik-freiburg.de076127040100

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 27, 2026